Welcure Drugs & Pharmaceuticals

11.52
-0.48
(-4.00%)
ann
Q4 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
Market Cap
129.60 Cr
EPS
-0.13
PE Ratio
67.76
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
15.81
52 Week Low
4.30
PB Ratio
1.27
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,677.60
#1 4,02,512.40
35.10
#1 49,887.20
12.06
#1 9,648
-18.99
42.28
6,612.00
1,75,527.80
80.12
8,184.00
0.89
1,600
23.05
63.47
1,465.70
1,18,372.10
22.44
26,520.70
14.17
4,155
30.28
44.20
3,174.70
1,07,446.30
55.71
10,785.70
11.59
1,656
10.91
44.55
1,251.20
1,04,407.10
#1 18.47
28,905.40
12.36
5,578
21.14
67.52
2,467.70
1,01,812.00
51.37
10,615.60
19.57
1,942
-10.91
48.86
930.00
93,579.80
20.04
19,831.50
13.82
3,831
-0.19
63.14
1,957.70
89,377.00
27.25
20,141.50
#1 19.94
1,936
#1 112.49
43.05
1,147.80
66,664.40
19.29
29,559.20
17.55
3,169
-0.50
43.00
30,455.00
64,714.70
45.75
6,097.20
10.80
1,201
27.83
50.48
Forecast
Actual
Growth Rate
Revenue Growth
-50.00 %
Net Income Growth
-300.00 %
Cash Flow Change
-218.18 %
ROE
-294.34 %
ROCE
-294.34 %
EBITDA Margin (Avg.)
-434.36 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
0
0
0
0
0
0
0
0
0
56
Expenses
0
0
0
0
0
0
0
0
0
0
52
EBITDA
0
0
0
0
0
0
0
0
0
-0
5
Operating Profit %
7 %
32 %
31 %
-41 %
3 %
-12 %
41 %
22 %
0 %
0 %
5 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
0
0
0
0
-0
5
Tax
0
0
0
0
0
0
0
0
0
0
1
Net Profit
0
0
0
0
0
0
0
0
0
-0
4
EPS in ₹
0.00
0.07
0.02
-0.02
0.00
-0.01
0.05
0.02
0.08
-0.13
0.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
0
0
0
0
0
0
0
0
2
1
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
0
0
0
0
0
0
0
0
0
0
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
0
0
0
0
1
1
Total Liabilities
0
0
0
0
0
0
0
0
2
1
Current Liabilities
0
0
0
0
0
0
0
0
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Equity
-0
0
0
0
0
0
0
0
2
1
Reserve & Surplus
-12
-12
-12
-12
-12
-12
-12
-12
-12
-12
Share Capital
12
12
12
12
12
12
12
12
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
0
0
0
0
0
-0
0
Investing Activities
0
0
0
0
0
0
0
0
0
0
Operating Activities
0
-0
0
0
0
0
0
0
0
-0
Financing Activities
0
0
0
0
0
0
0
0
-0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
14.12 %
14.12 %
14.12 %
14.12 %
14.12 %
14.12 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
73.82 %
73.81 %
75.07 %
76.27 %
76.04 %
76.91 %
88.34 %
93.73 %
93.64 %
93.68 %
94.28 %
93.87 %
93.69 %
93.14 %
93.55 %
98.79 %
98.99 %
Others
12.04 %
12.05 %
10.80 %
9.59 %
9.82 %
8.95 %
11.65 %
6.26 %
6.34 %
6.32 %
5.72 %
6.13 %
6.31 %
6.86 %
6.45 %
1.21 %
1.01 %
No of Share Holders
16,542
16,524
17,380
18,909
18,951
20,463
24,699
29,075
29,013
29,251
29,593
29,957
31,530
31,045
30,218
30,605
32,366

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 11.15 11.92
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 10.31 9.25
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 7.69 8.07
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 7.33 7.69

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance2 days ago
Announcement Pursuant To Regulation 32 Of SEBI (LODR) Regulations 2015 - Non Applicability Of Filing Statement Of Deviation / Variation In Utilization Of Funds For Quarter And Year Ended 31St March 20252 days ago
Announcement under Regulation 30 (LODR)-Change in Management2 days ago
Audited Standalone Financial Results And Audited Standalone Financial Statements Along With AuditorS Report Of The Company For The Quarter And Year Ended March 31 20252 days ago
Board Meeting Outcome for Outcome Of Board Meeting2 days ago
Board Meeting Intimation for For Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March 2025 Alongwith Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March 2025May 20, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 14, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMay 14, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals LimitedMay 14, 2025
Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.May 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 06, 2025
Appointment of Company Secretary and Compliance OfficerMay 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 06, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday 06Th May 2025.May 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorMay 06, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Closure of Trading WindowMar 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerFeb 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Integrated Filing (Financial)Feb 14, 2025
Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday 14 February 2025.Feb 14, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday 14 February 2025.Feb 14, 2025
Statement Of Deviation Variation Under Regulation 32 Of SEBI (LODR)Regulation 2015Feb 10, 2025
Board Meeting Intimation for Intimation Of Meeting Of BOD Under Regulation 29 Of The SEBI(LODR) Regulation 2015.Feb 10, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 23, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Wednesday 22Nd January 2025Jan 22, 2025
Submission Of SDD Compliance Certificate Under Regulation 3(5) And 3(6) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 For The Quarter Ended December 31St Jan 21, 2025
Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015.Jan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 04, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 03, 2024
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd. Held On Today I.E. Monday, 02Nd December, 2024.Dec 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Submission Of Half Yearly Disclosures On Related Party Transactions For A Period From 1St April, 2024 To 30Th September, 2024Nov 14, 2024
Unaudited Financial Results Of The Company Along With TheLimited Review Report As Issued By Statutory Auditor Of The Company For The 2Nd Quarter And HalfYear Ended On 30Th September 2024.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals LimitedHeld On Today I.E. Thursday, 14Th November, 2024.Nov 14, 2024
Board Meeting Intimation for Postponement Of Board MeetingNov 13, 2024
Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015.Nov 07, 2024
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 23, 2024
Notice Of Forfeiture Of Partly Paid Up Shares Of The CompanyOct 21, 2024
Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd.Oct 21, 2024
Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements),Regulations, 2015Oct 17, 2024
Statement Of Investor Grievances Under Regulation 13 (3) Of SEBI (LODR) Regulations, 2015Oct 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024

Technical Indicators

RSI(14)
Neutral
62.24
ATR(14)
Volatile
0.72
STOCH(9,6)
Neutral
72.71
STOCH RSI(14)
Neutral
41.53
MACD(12,26)
Bullish
0.01
ADX(14)
Strong Trend
34.42
UO(9)
Bearish
62.31
ROC(12)
Uptrend And Accelerating
2.40
WillR(14)
Neutral
-46.15